Thiel, U. ; Wolf, P. ; Wawer, A. ; Blaeschke, F. ; Grunewald, T.G. 
; von Lüttichau, I. ; Klingebiel, T. ; Bader, P. ; Borkhardt, A. ; Laws, H.-J. ; Handgretinger, R. ; Lang, P. ; Schlegel, P. ; Eyrich, M. ; Gruhn, B. ; Ehninger, G. ; Koscielniak, E. ; Klein, C. ; Sykora, K.-W. ; Holler, E. ; Mauz-Körholz, C. ; Woessmann, W. ; Richter, G.H. ; Schmidt, A. ; Peters, C. ; Dirksen, U. ; Jürgens, H. ; Bregni, M. ; Burdach, S.
; von Lüttichau, I. ; Klingebiel, T. ; Bader, P. ; Borkhardt, A. ; Laws, H.-J. ; Handgretinger, R. ; Lang, P. ; Schlegel, P. ; Eyrich, M. ; Gruhn, B. ; Ehninger, G. ; Koscielniak, E. ; Klein, C. ; Sykora, K.-W. ; Holler, E. ; Mauz-Körholz, C. ; Woessmann, W. ; Richter, G.H. ; Schmidt, A. ; Peters, C. ; Dirksen, U. ; Jürgens, H. ; Bregni, M. ; Burdach, S. 
Abstract
Background: Risk stratification criteria for patients with Ewing's sarcoma family of tumors (ESFT) are still limited. We hypothesized divergent human leukocyte antigen (HLA) patterns in ESFT patients and compared HLA-A, -B and -DR phenotype frequencies of patients with advanced ESFT with those of healthy controls. Patients: HLA types of all German Caucasian patients with advanced ESFT and ...
Owner only: item control page
Altmetric